Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Non-Performing Assets / Total Loans data is not available.
| Income Statement Financials | |
-- |
|
$-17.66M |
|
-- |
|
-- |
|
$19.15M |
|
$-19.15M |
|
$1.49M |
|
$-17.66M |
|
$-17.66M |
|
$-17.66M |
|
$-17.66M |
|
$-17.66M |
|
$-17.66M |
|
$-19.15M |
|
$-19.52M |
|
12.24M |
|
12.24M |
|
$-1.44 |
|
$-1.44 |
|
| Balance Sheet Financials | |
$122.83M |
|
$0.25M |
|
$2.26M |
|
$125.08M |
|
$13.33M |
|
-- |
|
$0.76M |
|
$14.09M |
|
$110.99M |
|
$110.99M |
|
$110.99M |
|
12.25M |
|
| Cash Flow Statement Financials | |
$-33.02M |
|
$35.87M |
|
-- |
|
$17.87M |
|
$20.71M |
|
$2.85M |
|
$3.28M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.21 |
|
|
Non-Performing Assets / Total Loans |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-33.02M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.91% |
|
-15.91% |
|
-14.12% |
|
-15.91% |
|
$9.06 |
|
$-2.70 |
|
$-2.70 |
|